AHR and lung carcinoma: In addition, ligand-induced AhR signals in lung cancer cells upregulate the expression of osteopontin (OPN) through AhR and NF-κB pathways interplay, and inhibition of AhR by the antagonist desmosflavone (DMF) reverses these effects [80].